26 results
424B5
GLUE
Monte Rosa Therapeutics Inc
26 Oct 23
Prospectus supplement for primary offering
4:55pm
commitment basis. This prospectus may be used in connection with any offering of our securities through any of these methods or other methods described … agreement with dealers, acting as standby underwriters. We may pay the standby underwriters a commitment fee for the securities they commit to purchase
PRE 14A
pmwevqch37 qqmu
12 Apr 23
Preliminary proxy
4:07pm
S-3
mjz2w06u8chmitlschvg
1 Jul 22
Shelf registration
5:01pm
S-3
EX-1.2
9rdky5j 46d
1 Jul 22
Shelf registration
5:01pm
DEF 14A
n4s0orogolk4x
27 Apr 22
Definitive proxy
4:10pm
10-K
cfbg8
29 Mar 22
Annual report
4:15pm
424B4
rr6e76sdy
25 Jun 21
Prospectus supplement with pricing info
6:08am
S-1/A
6c24i4u kt2cwo
9 Jun 21
IPO registration (amended)
4:51pm
S-1
EX-10.6
6p4e 4pvqbmp
4 Jun 21
IPO registration
9:07am
S-1
EX-10.1
2nwy wtvp
4 Jun 21
IPO registration
9:07am
S-1
9jdml4w5
4 Jun 21
IPO registration
9:07am
S-1
EX-10.5
vdzm9
4 Jun 21
IPO registration
9:07am
S-1
EX-3.1
pygmo
4 Jun 21
IPO registration
9:07am